In the midst of a persistent fight against the opioid crisis affecting Texas communities, including Laredo, local and state leaders are increasingly emphasizing harm reduction strategies to save lives ...
In 2023, the American Academy of Pediatrics published a clinical practice guideline recommending weight-loss medications, including glucagon-like peptide-1 (GLP-1) receptor agonists, as a supplement ...